T1	Participants 0 70	Risperidone dosing in children and adolescents with autistic disorder:
T2	Participants 175 212	children and adolescents with autism.
T3	Participants 213 245	Patients (N = 96; 5-17 years)
T4	Participants 781 816	significantly only in the high-dose
T5	Participants 908 947	more frequently in high-versus low-dose
